Want to see IN:AUROPHARMA full AI Analyst Report?
Total Valuation
Aurobindo Pharma Ltd has a market cap or net worth of ₹951.27B. The enterprise value is ₹731.37K.
Market Cap₹951.27B
Enterprise Value₹731.37K
Share Statistics
Aurobindo Pharma Ltd has 575,377,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding575,377,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aurobindo Pharma Ltd’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.33%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.33%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee11.52M
Profits Per Employee1.20M
Employee Count29,209
Asset Turnover0.58
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of Aurobindo Pharma Ltd is 25.8. Aurobindo Pharma Ltd’s PEG ratio is 24.40.
PE Ratio25.8
PS Ratio2.25
PB Ratio2.00
Price to Fair Value2.00
Price to FCF26.80
Price to Operating Cash Flow33.13
PEG Ratio24.40
Income Statement
In the last 12 months, Aurobindo Pharma Ltd had revenue of 336.53B and earned 35.05B in profits. Earnings per share was 60.34.
Revenue336.53B
Gross Profit131.96B
Operating Income50.78B
Pretax Income51.12B
Net Income35.05B
EBITDA72.74B
Earnings Per Share (EPS)60.34
Cash Flow
In the last 12 months, operating cash flow was 28.85B and capital expenditures -13.63B, giving a free cash flow of 15.22B billion.
Operating Cash Flow28.85B
Free Cash Flow15.22B
Free Cash Flow per Share26.45
Dividends & Yields
Aurobindo Pharma Ltd pays an annual dividend of ₹4, resulting in a dividend yield of 0.24%
Dividend Per Share₹4
Dividend Yield0.24%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change58.93%
50-Day Moving Average1.60K
200-Day Moving Average1.37K
Relative Strength Index (RSI)55.69
Average Volume (3m)38.99K
Important Dates
Aurobindo Pharma Ltd upcoming earnings date is Nov 9, 2026, TBA (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
Aurobindo Pharma Ltd as a current ratio of 1.81, with Debt / Equity ratio of 0.00%
Current Ratio1.81
Quick Ratio1.15
Debt to Market Cap0.10
Net Debt to EBITDA-0.25
Interest Coverage Ratio13.22
Taxes
In the past 12 months, Aurobindo Pharma Ltd has paid 16.09B in taxes.
Income Tax16.09B
Effective Tax Rate0.31
Enterprise Valuation
Aurobindo Pharma Ltd EV to EBITDA ratio is 10.17, with an EV/FCF ratio of 26.16.
EV to Sales2.20
EV to EBITDA10.17
EV to Free Cash Flow26.16
EV to Operating Cash Flow13.42
Balance Sheet
Aurobindo Pharma Ltd has ₹105.85B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹105.85B billion.
Cash & Marketable Securities₹105.85B
Total Debt₹0.00
Net Cash₹105.85B
Net Cash Per Share₹183.96
Tangible Book Value Per Share₹561.29
Margins
Gross margin is 44.94%, with operating margin of 15.09%, and net profit margin of 10.41%.
Gross Margin44.94%
Operating Margin15.09%
Pretax Margin15.19%
Net Profit Margin10.41%
EBITDA Margin21.61%
EBIT Margin16.33%
Analyst Forecast
The average price target for Aurobindo Pharma Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.09%
EPS Growth Forecast9.61%